EcoDrugPlus

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSOTSG00005005725
Gene Symbol: AKR1B1.1
1 Cross references
341 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSOTSG00005005935
Gene Symbol: AKR1B1.1
1 Cross references
340 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSOTSG00005005732
Gene Symbol: AKR1B1.2
1 Cross references
334 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSOTSG00005023504
Gene Symbol: AKR1B1.2
1 Cross references
266 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSOTSG00005008039
Gene Symbol: GAA
1 Cross references
227 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSOTSG00005047151
Gene Symbol: LOC112262961
3 Cross references
196 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSOTSG00005036286
Gene Symbol: LOC112249680
3 Cross references
196 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSOTSG00005021855
Gene Symbol: LOC112220245
3 Cross references
143 Possible Orthologues:

Alpha-2c Adrenergic Receptor-Like

Ensembl ID : ENSOTSG00005018167
Gene Symbol: LOC112239219
3 Cross references
160 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSOTSG00005034666
Gene Symbol: LOC112219863
2 Cross references
183 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSOTSG00005005693
Gene Symbol: LOC112216529
3 Cross references
225 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSOTSG00005036707
Gene Symbol: AOC1
1 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).